The combined action of p-aminosalicylic acid and streptomycin with isonicotinic acid hydrazide in vitro.
D010131:Aminosalicylic Acid / Q000494:pharmacology*; D066298:In Vitro Techniques; D007538:Isoniazid; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009525:Niacin; D009539:Nicotinic Acids / Q000494:pharmacology*; D013307:Streptomycin / Q000494:pharmacology*
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/effects; PARA-AMINOSALICYLIC ACID/effects; STREPTOMYCIN/effects
Lancet. 1952 Nov 1;2(6740):854-8
12991613
Am Rev Tuberc. 1952 Jun;65(6):768-70
14924202
Ned Tijdschr Geneeskd. 1950 Nov 18;94(46):3347-52
14806570
Lancet. 1952 Nov 1;2(6740):843-9
12991611
Rev Tuberc. 1952;16(7-8):670-8
13038301
Lancet. 1952 Nov 1;2(6740):849-53
12991612
Am Rev Tuberc. 1952 Jun;65(6):765-7
14924201
Am Rev Tuberc. 1952 Jun;65(6):761-4
14924200